Back to all stories

DOJ Backs NYU Langone in Dispute With Letitia James Over Transgender Youth Treatments

The U.S. Department of Justice, in a letter from Deputy Attorney General Todd Blanche sent Wednesday, warned New York Attorney General Letitia James that federal law does not require NYU Langone Health to provide certain transgender‑related treatments to minors and said DOJ would defend the hospital if she sues. The letter challenges James’ claim that the hospital’s decision last month to discontinue its Transgender Youth Health Program violates a New York anti‑discrimination statute covering sex, gender identity and disability, arguing NYU Langone is exercising medical discretion rather than discriminating. NYU Langone says it shut down the program after the departure of its medical director and amid a changing “regulatory environment,” while maintaining pediatric mental‑health services and noting it does not perform what DOJ’s letter calls “sex‑rejecting procedures” on minors. Blanche cites the Supreme Court’s 2025 decision in United States v. Skrmetti, which upheld Tennessee’s ban on certain transgender medical care for minors, to buttress DOJ’s view that the hospital’s diagnosis‑based criteria are lawful. The confrontation sets up a potential federal‑state showdown over who gets to define discrimination and control medical practice in the politically charged arena of youth gender care, and signals the Trump Justice Department’s willingness to side with institutions that pull back from treating minors.

Transgenderism/Transexualism Federal–State Legal Conflicts

📌 Key Facts

  • Deputy Attorney General Todd Blanche sent a letter Wednesday stating DOJ disagrees with New York AG Letitia James’ finding that NYU Langone’s policy is discriminatory.
  • DOJ says federal law does not require NYU Langone to provide certain transgender‑related treatments to minors and pledges to defend the hospital if James sues.
  • NYU Langone ended its Transgender Youth Health Program last month after its medical director left, but says pediatric mental‑health services will continue.
  • Blanche cites the Supreme Court’s United States v. Skrmetti decision upholding Tennessee’s ban on certain transgender care for minors as supporting DOJ’s position.
  • James had given NYU Langone 10 days to reinstate its program, arguing the hospital is violating a state law that bars discrimination based on sex, gender identity and disability.

📊 Relevant Data

As of 2025, 3.3% of US youth aged 13-17 identify as transgender, up from 0.73% in 2016-2017.

How Many Adults and Youth Identify as Transgender in the United States? — Williams Institute at UCLA School of Law

Among US youth aged 13-17 identifying as transgender in 2025, the rates vary by race/ethnicity: 4.2% for American Indian or Alaska Native, 4.3% for biracial/multiracial, 3.6% for White, 3.4% for Asian American or Pacific Islander, 2.9% for Latinx, and 2.2% for Black.

How Many Adults and Youth Identify as Transgender in the United States? — Williams Institute at UCLA School of Law

In a 2024 German study of young people diagnosed with gender dysphoria, the persistence rate (continuing to have the diagnosis after 5 years) was 27.3% for adolescent females aged 15-19, the lowest among groups, while it was 49.7% for young males aged 20-24.

The Gender Dysphoria Diagnosis in Young People Has a “Low Stability” Over Time: New Longitudinal Study from Germany — Society for Evidence-Based Gender Medicine (SEGM)

A 2025 HHS report found weak evidence for benefits of puberty blockers and gender-affirming hormones for pediatric gender dysphoria, noting that 92% of youth who receive puberty blockers progress to cross-sex hormones within 12-36 months.

Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices — U.S. Department of Health and Human Services (HHS)

📰 Source Timeline (1)

Follow how coverage of this story developed over time